SCHEMBL10156743

SCHEMBL10156743

CSc1nc(Cl)cc(Nc2ccnc(Cl)c2)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.63
▸ KMT2A Q03164 2/20 0.63
▸ GAA P10253 1/20 0.63
▸ SMN1; SMN2 Q16637 1/20 0.63
▸ PPARA Q07869 6/20 0.43
▸ PPARG P37231 5/20 0.43
▸ RXRA P19793 1/20 0.43
▸ RXRG P48443 1/20 0.43
▸ PPARD Q03181 1/20 0.43
▸ TP53 P04637 2/20 0.40
▸ ALOX5 P09917 4/20 0.40
▸ AURKA O14965 1/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ POLA1 P09884 1/20 0.39
▸ PIK3CA P42336 1/20 0.39
▸ MAPK8 P45983 1/20 0.39
▸ MAPK9 P45984 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2090416 0.80 MEN1 (0.73) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL10156010 0.77 MEN1 (0.64) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL10995605 0.75 MEN1 (0.70) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL3079698 0.74 KMT2A (0.56) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL10156777 0.74 POLB (0.42) MEN1KMT2AGAASMN1; SMN2PIK3CA
SCHEMBL10157859 0.74 MEN1 (0.60) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL4397422 0.72 KMT2A (0.51) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL2614898 0.72 KMT2A (0.57) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL10157201 0.71 MEN1 (0.53) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL10156557 0.71 TP53 (0.59) MEN1KMT2AGAASMN1; SMN2PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 MEN1 724/4885KMT2A 103/4885GAA 3821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback